What's new? Log in Free sign up

Pear Therapeutics (PEAR) News and press releases

Company Profile

News

From Benzinga Pro

12 Health Care Stocks Moving In Friday's Intraday Session

Pear Therapeutics Explores Strategic Options; May Seek Reorganization If Unable To Complete Transaction

Biotech, News, Penny Stocks, Health Care, Movers, General

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

Pear Therapeutics Announces Inclusion Of reSET And reSET-O On The January 2023 Florida Medicaid Preferred Drug List

Pear’s prescription digital therapeutics (PDTs), reSET® and reSET-O®, are included on the January 2023 Florida Medicaid Preferred Drug List (PDL), effective January 1, 2023 Florida Medicaid is covering

Pear Therapeutics And Spero Health To Expand Access To Prescription Digital Therapeutics For People In Recovery Across Multiple Locations And States

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the expansion of its collaboration with Spero

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 258 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 325 companies set new 52-week lows.

12 Health Care Stocks Moving In Monday's After-Market Session

Pear Therapeutics's Return On Capital Employed Insights

Stocks That Hit 52-Week Lows On Thursday

Thursday's session saw 329 companies set new 52-week lows.

Press releases

From Benzinga Pro

Pear Therapeutics Announces Process Exploring Strategic Alternatives

Pear Therapeutics, Inc. (NASDAQ:PEAR) ("the Company"), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that it is engaged in a

Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the 43rd

Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in the BTIG

California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program

The California Department of Health Care Services (DHCS) selected Pear Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California's Contingency Management Program, to treat

Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics

COEUS' COEBRA™ Platform to Facilitate Value and Outcomes Based Agreements for Government and Commercial Payers Pear Therapeutics, Inc. (NASDAQ:PEAR) ("Pear"), the leader in developing and commercializing

Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States

Spero Health, one of the nation's largest office-based outpatient opioid treatment providers for individuals in recovery, to expand patient access to Pear's prescription digital therapeutics (PDTs) for the treatment of

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.